![Simon Douglas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Douglas
Vorsitzender bei
FUSION ANTIBODIES PLC
Vermögen: 112 980 $ am 31.07.2026
Profil
Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FUSION ANTIBODIES PLC 0,69 % | 17.02.2026 | 861 062 ( 0,69 % ) | 112 980 $ | 31.07.2026 |
Aktive Positionen von Simon Douglas
| Unternehmen | Position | Beginn |
|---|---|---|
| FUSION ANTIBODIES PLC | Vorsitzender | 01.09.2011 |
C-Major Ltd.
 C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Vorsitzender | 01.09.2019 |
Ehemalige bekannte Positionen von Simon Douglas
| Unternehmen | Position | Ende |
|---|---|---|
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Vorsitzender | 23.03.2026 |
| CAMBRIDGE NUTRITIONAL SCIENCES PLC | Vorsitzender | 22.04.2024 |
Biofortuna Ltd.
 Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Vorstandsvorsitzender | 01.01.2019 |
Lab901 Ltd.
 Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Vorsitzender | 01.01.2011 |
Invitrogen Holdings Ltd.
 Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Vorstandsvorsitzender | 01.01.2006 |
Ausbildung von Simon Douglas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Researches and develops medical diagnostic products | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNA Research Innovations Ltd.
 DNA Research Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Conducts DNA based research | Commercial Services |
Lab901 Ltd.
Lab901 Ltd. Medical SpecialtiesHealth Technology Develops and manufactures laboratory processing products | Health Technology |
Cambridge Nutritional Sciences Plc
 Cambridge Nutritional Sciences Plc Medical SpecialtiesHealth Technology Engages in selling of medical products, primarily in the immunoassay, in-vitro diagnostics market | Health Technology |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries Manufactures paints & coatings | Process Industries |
Zeneca, Inc. | |
Fusion Antibodies Plc
 Fusion Antibodies Plc Medical/Nursing ServicesHealth Services Develops antibody-based therapeutic products | Health Services |
Invitrogen Holdings Ltd.
Invitrogen Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Biofortuna Ltd.
Biofortuna Ltd. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and diagnostics development and contract manufacturing solutions | Commercial Services |
C-Major Ltd.
C-Major Ltd. Internet Software/ServicesTechnology Services Develops online platform which produces medical devices to reduce the risk of needle stick injuries | Technology Services |
HexagonFab Ltd.
HexagonFab Ltd. Medical SpecialtiesHealth Technology Develops practical measurement tools that helps scientists | Health Technology |
DRI Ltd. (United Kingdom) |
